SCI收录文章

1. Jin J#, Wang JX#, Chen FF, Wu DP, Hu J, Zhou JF, Hu JD, Wang JM, Li JY, Huang XJ, Ma J, Ji CY, Xu XP, Yu K, Ren HY, Zhou YH, Tong Y, Lou YJ, Ni WM, Tong HY, Wang HF, Mi YC, Du X, Chen BA, Shen Y, Chen Z, Chen SJ, Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial.

Lancet Oncol. 2013, 14(7): 599-608 (SCI-IF:25.117)

2. Hong-Hu Zhu, De-Pei Wu, Jie Jin, Jian-Yong Li, Jun Ma, Jian-Xiang Wang, Hao Jiang, Sai-Juan Chen, and Xiao-Jun Huang*, Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial,

J Clin Onc, 2013 Nov 20;31(33):4215-21 (SCI-IF:18.038)

3. Shaorong Gao, Gang Chang, Shuai Gao, Xinfeng Hou, Zijian Xu, Yanfeng Liu, Lan Kang, Yu Tao, Wenqiang Liu, Bo Huang, Xiaochen Kou, Jiayu Chen, Lei An, Tao Cheng, Tao Cai, Jianhui Tian, Kai Miao, Keqian Di, Zhirong Wang, and Kun Tan. High-throughput sequencing reveals the disruption of methylation of imprinted gene in induced pluripotent stem cells.

Cell Research. Accepted (SCI-IF:10.526)

4. Wang J, Xu Z, Liu L, Gale RP, Cross NC, Jones AV, Qin T, Ai X, Xu J, Zhang T, Sun X, Li Q, Zhang P, Zhang Y, Xiao Z. JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms.

Leukemia. 27, 1763–1767. (SCI-IF:10.164)

5. Liu Y, Cheng H, Gao S, Zou Z, He F, Hu L, Hou D, Lu X, Li Y, Zhang H, Xu J, Kang L, Wang Q, Yuan W, Gao S, Cheng T*. Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells.

Leukemia. 2013 Oct 22. [Epub ahead of print] (SCI-IF:10.164)

6. Yanxin Li, Haizhong Feng, Haihui Gu, Dale W. Lewis, Youzhong Yuan, Lei Zhang, Hui Yu, Peng Zhang, Haizi Cheng, Weimin Miao, Weiping Yuan, Shi-Yuan Cheng, Susanne M. Gollin, and Tao Cheng*.The p53-PUMA axis suppresses iPSC generation.

Nat Commun. 2013 Jul 19;4:2174. (SCI-IF:10.015)

7. Yuanfu Xu, Hongmei Li, Besnik Bajrami, Hyunjeong Kwak, Shannan Cao, Peng Liu, Jiaxi Zhou, Yuan Zhou, Haiyan Zhu, Keqiang Ye, and Hongbo R. Luo, Cigarette smoke (CS) and nicotine delay neutrophil spontaneous death via suppressing production of diphosphoinositol pentakisphosphate

Proc Natl Acad Sci USA. 2013 May 7;110(19):7726-31. (SCI-IF:9.737)

8. Yuan Zhou, Yunhui Hu, Ming Yang, Parmjit Jat, Kaiyong Li, Ylenia Lombardo, Dongsheng Xiong, Charles Coombes, SelinaRaguz, ErnestoYagüe.The miR-106b~25 cluster promotes bypass of doxorubicin-induced senescenceand increase in motility and invasion by targeting the E-cadherin transcriptionalactivatior EP300.

Cell Death & Differentiation (Accepted) (SCI-IF:IF:8.371)

9. Miao W, Xufeng R, Park MR, Gu H, Hu L, Kang JW, Ma S, Liang PH, Li Y, Cheng H, Yu H, Epperly M, Greenberger J, Cheng T. Hematopoietic Stem Cell Regeneration Enhanced by Ectopic Expression of ROS-detoxifying Enzymes in Transplant Mice.

Mol Ther. 2013;21(2):423-32. (SCI-IF:7.041)

10. Ji-Ying Wang, Pei Yu, Shuying Chen, Haiyan Xing, Yirui Chen, Min Wang, Kejing Tang, Zheng Tian, Qing Rao*, Jianxiang Wang*., Activation of Rac1 GTPase promotes leukemia cell chemotherapy resistance, quiescence and niche interaction.

Mol Oncol. 2013, 7: 907-916 (SCI-IF:6.701)

11. Wang Y, Zhang Z, Chi Y, Zhang Q, Xu F, Yang Z, Meng L, Yang S, Yan S, Mao A, Zhang J, Yang Y, Wang S, Cui J, Liang L, Ji Y, Han ZB, Fang X, Han ZC. Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation.

Cell Death Dis. 2013 Dec 5;4:e950. (SCI-IF:IF:6.044)

12. An G, Xu Y, Shi L, Zhong S, Deng S, Xie Z, Sui W, Zhan F, Qiu L. Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no prognostic value.

Haematologica 2013 Nov 8. [Epub ahead of print] (SCI-IF:5.935)

13. Tian C, Zheng G, Cao Z, Li Q, Ju Z, Wang J, Yuan W, Cheng T*. Hes1 mediates the different responses of hematopoietic stem and progenitor cells to T cell leukemic environment.

Cell Cycle. 2013 Jan 15;12(2):322-31. (SCI-IF:5.243)

Guoqiang Chang, Jian Wang, Hongju Zhang, Yujuan Zhang, Chijuan Wang, Hua Xu, Hairui Zhang, Li Ma, Qinghua Li, Tianxiang Pang*. CD44 targets Na+/H+ exchanger 1 to mediate MDA-MB-231 cells metastasis via the regulation of ERK1/2.

Brit J Cancer. (Accepted) (SCI-IF 5.082)

15. Jingcao Huang#, Shuiliang Wang#, Hui Lyu, Bo Cai, XiaoHe Yang, Jianxiang Wang* and Bolin Liu*, The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells

Mol Cancer, 2013, 12:134 (SCI-IF:5.134)

16. Li H, Zhao H, Xue F, Zhang X, Zhang D, Ge J, Yang Y, Xuan M, Fu R, Yang R. Reduced expression of MIR409-3p in primary immune thrombocytopenia。

Br J Haematol. 2013 ;161(1):128-35. (SCI-IF:4.942)

17. Fu R, Zhang L and Yang R. Paediatric essential thrombocythaemia: clinical and molecularfeatures, diagnosis and treatment.

Br J Haematolol 2013,163(3):295-302 (SCI-IF:4.942)

18. Shao Y, Li X, Shi J, Ge M, Huang J, Huang Z, Zhang J, Nie N, Zheng Y. Cyclosporin combined with levamisole for refractory or relapsed severe aplastic anaemia.

Br J Haematol. 162(4): 552-555. (2013) (SCI-IF:4.942)

19. Bai H, Xie YL, Gao YX, Cheng T, Wang ZZ. The Balance of Positive and Negative Effects of TGF-ß Signaling Regulates the Development of Hematopoietic and Endothelial progenitors in Human Pluripotent Stem Cells.

Stem Cells Dev. 2013 Jun 13. (SCI-IF:4.67)

20. Chen F, Zhou K, Zhang L, Ma F, Chen D, Cui J, Feng X, Yang S, Chi Y, Han Z, Xue F, Rong L, Ge M, Wan L, Xu S, Du W, Lu S, Ren H, Han Z.Mesenchymal stem cells induce granulocytic differentiation of acute promyelocytic leukemic cells via IL-6 and MEK/ERK pathways.

Stem Cells Dev. 2013 Jul 1;22(13):1955-67. (SCI-IF:4.67)

21. Yan C, Li S, Li Z, Peng H, Yuan X, Jiang L, Zhang Y, Fan D, Hu X, Yang M, Xiong D. Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma.

Mol Pharm. 2013 Jan 7; 10(1):142-151 (SCI-IF:4.57)

Saha MN, Qiu L, Chang H. Targeting p53 by small molecules in hematologicalmalignancies.

J Hematol Oncol. 2013 Mar 27;6:23. (SCI-IF:4.458)

23. Su W, Wang L, Zhou M, Liu Z, Hu S, Tong L, Liu Y, Fan Y, Kong D, Zheng Y, Han Z, Wu JC, Xiang R, Li Z.Human embryonic stem cell-derived endothelial cells as cellular delivery vehicles for treatment of metastatic breast cancer.

Cell Transplant. 2013;22(11):2079-90. (SCI-IF:4.422)

Li S, Zhai Q, Zou D, Meng H, Xie Z, Li C, Wang Y, Qi J, Cheng T, Qiu L. A pivotal role of bone remodeling in granulocyte colony stimulating factor induced hematopoietic stem/progenitor cells mobilization.

J Cell Physiol. 2013 May;228(5):1002-9. (SCI-IF:4.218)

25. Li W, Fan D, Yang M, Yan Y, Shi R, Cheng J, Li Z, Zhang M, Wang J, Xiong D，Cytosine arabinoside promotes cytotoxic effect of T cells on leukemia cells mediated by bispecific antibody.

Hum Gene Ther. 2013;24(8):751-60 (SCI-IF:4.019)

26. Lu Y, Gu X, Chen L, Yao Z, Song J, Niu X, Xiang R, Cheng T, Qin Z, Deng W, Li LY*. Interferon-c produced by tumor-infiltrating NK cells and CD4+ T cells downregulates TNFSF15 expression in vascular endothelial cells.

Angiogenesis. 2013 Oct 20 (SCI-IF:3.972)

27. Dehui Zou, Gang An, Guoqing Zhu, Jinhong Wang, Lihui Shi, Hengxing Meng, Yan Xu, Weiwei Sui, Shuhui Deng, Fenghuang Zhan, Lugui Qiu. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias

Biology of Blood and Marrow Transplantation (SCI-IF:3.94)

28. Yang ZX, Han ZB, Ji YR, Wang YW, Liang L, Chi Y, Yang SG, Li LN, Luo WF, Li JP, Chen DD, Du WJ, Cao XC, Zhuo GS, Wang T, Han ZC. CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties.

PLoS One. 2013;8(3):e59354 (SCI-IF:3.73)

29. Xiao Li, Zhi-jian Xiao(Co-first author), Chun-kang Chang, Feng Xu, Ling-yun Wu, Qi He, Ze-feng Xu, Luxi Song, Zheng Zhang, Li-yu Zhou, Ji-ying Su, Xi Zhang, Juan Guo. Distinct Clinical and Experimental Characteristics in the Patients Younger than 60 Years Old with Myelodysplastic Syndromes.(共同第一)

PLoS One,2013,8(2):e57392. (SCI-IF:3.73)

30. Zhang Y, Dong F, Zhang N, Cheng H, Pang Y, Wang X, Xu J, Ding X, Cheng T, Gu J, Yuan W*. Suppression of cytochrome p450 reductase enhances long-term hematopoietic stem cell repopulation efficiency in mice.

PLoS One. 2013 Jul 26;8(7):e69913. (SCI-IF:3.73)

31. Jia Q, Zhang Q, Zhang Z, Wang Y, Zhang W, Zhou Y, Wan Y, Cheng T, Zhu X, Fang X, Yuan W*, Jia H*. Transcriptome Analysis of the Zebrafish Model of Diamond-Blackfan Anemia from RPS19 Deficiency via p53-Dependent and -Independent Pathways.

PLoS One. 2013 Aug 19;8(8):e71782. (SCI-IF:3.73)

32. Li X, Shi J, Ge M, Shao Y, Huang J, Huang Z, Zhang J, Nie N, Zheng Y. Outcomes of optimized over standard protocol of rabbit antithymocyte globulin for severe aplastic anemia: a single-center experience.

PLoS One. 8(3): e56648. (2013) (SCI-IF:3.73)

33. Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji Y, Wang J, Zhao H, Han ZC. MicroRNA-124 Suppresses Breast Cancer Cell Growth and Motility by Targeting CD151.

Cell Physiol Biochem. 2013 Jun 4;31(6):823-832. (SCI-IF:3.415)

34. Li G, Yuan L, Ren X, Nian H, Zhang L, Han ZC, Li X, Zhang X. The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis.

Clin Exp Immunol. 2013 Jul;173(1):28-37 (SCI-IF:3.409)

35. Qi A, Zhou H, Zhou Z, Huang X, Ma L, Wang H, Yang Y, Zhang D, Li H, Ren R, Yang R. Telomerase activity increased and telomere length shortened in peripheral blood cells from patients with immune thrombocytopenia.

J Clin Immunol. 2013;33(3):577-85. (SCI-IF:3.382)

36. Li H, Xuan M and Yang R. DNA methylation and primary immune thrombocytopenia.

Semin Hematol 2013;50Suppl 1:S116-26. (SCI-IF:3.357)

37. Shi R, Peng H, Yuan X, Zhang X, Zhang Y, Fan D, Liu X, Xiong D Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation

J Cell Biochem. 2013;114(8):1890-1900. (SCI-IF:3.062)

38. Chen D, Ma F, Xu S, Yang S, Chen F, Rong L, Chi Y, Zhao Q, Lu S, Han Z, Pang A, Han Z. Expression and role of Toll-like receptors on human umbilical cord mesenchymal stromal cells.

Cytotherapy. 2013 Apr;15(4):423-33. (SCI-IF:3.055)

39. Ma F, Chen D, Chi Y, Chen F, Li X, Han Z.The expression and role of miR-301a in human umbilical cord-derived mesenchymal stromal cells.

Cytotherapy. 2013 Dec;15(12):1511-6 SCI-IF:3.055)

40. Feng-kui Zhang, Li Zhang, Liping Jing, Kang Zhou, Huijun Wang, Guangxin Peng, Yang Li, Yuan Li, Jianping Li, Lei Ye, Lihui Shi, Huihui Fan, Xin Zhao, Yulin Chu, Yushu Hao, Jianxiang Wang. High-dose cyclophosphamide compared with antithymocyte globulin for treatment of acquired severe aplastic anemia.

Exp Hematol. 2013，41(4):328-34 (SCI-IF:2.907)

41. Xiang-Fei Yuan, Hong-Wei Peng, Ya-Hui Dingb, Ci-Hui Yan,Yan-Jun Zhang, Ming Yang and Dong-Sheng Xiong，Gene therapy in B-NHL cell line using adenovirus-mediated transfer of secretable trimeric TRAIL gene expression driven by CD20 promoter.

Experimental Hematology 2013;41:221-230 (SCI-IF:2.907)

42. Zhou H, Fu R，Wang H, Zhou F, Li H, Zhou Z, Zhang L, Yang R. Immune thrombocytopenia in the elderly: clinical coursein 525 patients from a single center in China.

Ann Hematol. 2013,92(1):79-87 (SCI-IF:2.866)

Li X, Shao Y, Ge M, Shi J, Huang J, Huang Z, Zhang J, Nie N, Zheng Y. A promising immunosuppressive strategy of cyclosporine alternately combined with levamisole is highly effective for moderate aplastic anemia.

Ann Hematol. 92(9): 1239-1247. (2013) (SCI-IF: 2.866)

44. Ru Y, Liu G, Bai J, Dong S, Nie N, Zhang H, Zhao S, Zheng Y, Zhu X, Nie G, Zhang F, Eyden B.Congenital dyserythropoietic anemia in China: a case report from two families and a review.

Ann Hematol. 2013 Nov 7 (SCI-IF: 2.866)

45. Hu Y, Cheng X, Li S, Zhou Y, Wang J, Cheng T, Yang M, Xiong D. Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins.

Cancer Chemother Pharmacol. 2013,72(4):789-98. (SCI-IF:2.795)

46. Gang An, Yan Xu, Lihui Shi, Dehui Zou, Shuhui Deng, Weiwei Sui, Zhenqing Xie,Mu Hao, Hong Chang, Lugui Qiu, t(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome.

Leukemia Res. 2013 Oct;37(10):1251-7 (SCI-IF:2.764)

Hongju Zhang, Guoqiang Chang, Jian Wang, Yani Lin, Li Ma, Tianxiang Pang*. CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatment.

Leukemia Res. 2013; 37(11): 1583-1591. (SCI-IF:2.764)

48. Wang J, Ai X, Gale RP, Xu Z, Qin T, Fang L, Zhang H, Pan L, Hu N, Zhang Y, Xiao Z. TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes.

Leukemia Res. 2013 Mar;37(3):305-11. (SCI-IF:2. 764)

49. Zhang Y, Hua C, Cheng H, Wang W, Hao S, Xu J, Wang X, Gao Y, Zu X, Cheng T, Yuan W*. Distinct sensitivity of CD8+CD4- and CD8+CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1- induced T-ALL.

Leukemia Res. 2013 Nov;37(11):1592-601 (SCI-IF:2.764)

50. Xin Zhao, Kang Zhou, Liping Jing, Li Zhang, Guangxin Peng, Yang Li, Lei Ye, Jianping Li, Huihui Fan,Yuan Li, Fengkui Zhang. Treatment of T-cell large granular lymphocyte leukemia with cyclosporine A:Experience in a Chinese single institution

Leukemia Res. 37 (2013) 547-551 (SCI-IF:2.764)

51. Shuning Wei, Siping Wang, Shaowei Qiu, Junyuan Qi, Yingchang Mi, Dong Lin, Chunlin Zhou, Bingcheng Liu, Wei Li, Ying Wang, Min Wang, Jianxiang Wang*, Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocation.

Leukemia Res, 2013, 37(9): 1010-1015 (SCI-IF:2.764)

52. Zhang S, Shao Y, Hou G, Bai J, Yuan W, Hu L, Cheng T, Zetterberg A, Zhang J. QM-FISH analysis of the genes involved in the G1/S checkpoint signaling pathway in triple-negative breast cancer.

Tumor Biol. 2013 Oct 5. [Epub ahead of print] (SCI-IF:2.518)

53. Zhang Y, Zhang M, Zhao S, Li X, Jia Z, Zhang L, Han ZC, Zhang X. Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation.

Int Immunopharmacol. 2013 Jan;15(1):114-20. (SCI-IF:2.417)

An G, Shi L, Xu Y, Zou D, Deng S, Sui W, Zhu G, Xie Z, Hao M, Sun Q, Zhan F,Qiu L. Prognostic value of high serum lactate dehydrogenase in plasma cell dyscrasias: a re-evaluation in the context of cytogenetic aberration data.(letter to editer)

Leuk Lymphoma. 2013 Nov;54(11):2556-9. (SCI-IF: 2.301)

Xu Y, Sui W, Deng S, An G, Wang Y, Xie Z, Yao H, Zhu G, Zou D, Qi J, Hao M,Zhao Y, Wang J, Chen T, Qiu L. Further stratification of patients with multiplemyeloma by International Staging System in combination with ratio of serum free κ to λ light chains.

Leuk Lymphoma. 2013 Jan;54(1):123-32. (SCI-IF: 2.301)

Huawen Li, Guoqiang Chang, Jian Wang, Lihong Wang, Weina Jin, Yani Lin, Yan Yan, Ruojun Wang, Wei Gao, Li Ma, Qinghua Li*, Tianxiang Pang*. Cariporide Sensitizes Leukemic Cells to TRAIL by Upregulation of Death Receptor 5 via ER stress CHOP dependent Mechanism.

Leuk Lymphoma. 2013 Nov 4. [Epub ahead of print] (SCI-IF:2.301)

57. Zhou K, Yu Z, Yi S, Li Z, An G, Zou D, Qi J, Zhao Y, Qiu L miR-29c down-regulation is associated with disease aggressiveness and poor survival in Chinese patients with chronic lymphocytic leukemia.

Leuk Lymphoma. 2013 Oct 21. [Epub ahead of print] (SCI-IF: 2.301)

Ge M, Zheng Y, Li X, Lu S, Li H, Chen F, Chen D, Shao Y, Shi J, Feng S. Differential expression profile of Th1/Th17/Th2-related chemokines and their receptors in patients with acquired bone marrow failure syndromes.

Hum Immunol. 74(2): 176-180. (2013) (SCI-IF: 2.298)

59. Zhang D, Zhang X, Ge M, Xuan M, Li H, Yang Y, Fu R, Zhou F, Zheng Y, Yang R. The polymorphisms of T cell-specific TBX21 gene may contribute to the susceptibility of chronic immune thrombocytopenia in Chinese population.

Hum Immunol. 2013 Nov 18. [Epub ahead of print] (SCI-IF:2.298)

60. Ge Jin, Li H, Gu D, Du W, Xue F, Sui T, Xu J, Yang R. PTPN22 -1123G > C polymorphism is associated with susceptibility to primary immune thrombocytopenia in Chinese population.

Platelets. 2013,24(6):448-453 (SCI-IF:2.24)

61. Xuan M, Li H, Fu R, Yang Y, Zhang D, Zhang X, Yang R. Lack of association between NR3C1 polymorphism and glucocorticoid resistance in Chinese patients with immune thrombocytopenia.

Platelets. 2013 Mar 25. [Epub ahead of print] (SCI-IF:2.24)

Guoqiang Chang, Hongju Zhang, Jian Wang, Yujuan Zhang, Hua Xu, Chijuan Wang, Hairui Zhang, Li Ma, Qinghua Li, Tianxiang Pang*. CD44 targets Wnt/beta-catenin pathway to mediate the proliferation of K562 cells.

Cancer Cell Int. (SCI-IF 2.093)

63. Yao Y, Liu S, Wang Y, Yuan W, Ding X, Cheng T, Shen Q, Gu J. Suppression of cytochrome P450 reductase expression promotes astrocytosis in subventricular zone of adult mice.

Neurosci Lett. 2013 May 30. (SCI-IF:2.026)

64. Xuan M, Xue F, Fu R, Yang Y, Zhang L, Tian M, Yang R.Retrospective analysis of 1,226 Chinese patients with haemophilia in a single medical centre.

J Thromb Thrombolysis. 2013 Nov 7. (SCI-IF:1.985)

65. Wang H, He Y, Zhai WJ, Wang M, Zhou Z, Zhao YX, Feng SZ, Han MZ. The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor hematopoietic stem cell transplantation for myeloid malignancies.

Swiss Med Wkly. 2013 Jan 8;143:w13717. (SCI-IF:1.821)

66. Lixia Zhang, Qinghua Li, Wei Li, Bingcheng Liu, Ying Wang, Dong Lin, Chunlin Zhou, Chengwen Li, Jianxiang Wang, Yingchang Mi*, Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22).

Int J Hematol, 2013，97:786–792 (SCI-IF:1.681)

67. Qihui Li，Lei Huai，Cuiping Zhang，Cuicui Wang，Yujjao Jia，Yirui Chen， Pei Yu，Houcai Wang，Qing Rao，Min Wang，Jianxiang Wang，Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways.

Int J Hematol，2013, 97: 617-623 (SCI-IF:1.681)

68. Shuchun wang. Yumei Chen . Yao Zou Yizhou Zheng •.Xiaofan Zhu .The progression risk factors of children with transfusion-independent non-severe aplastic anemia.

Int J Hematol (2013) 97:210–215. (SCI-IF:1.681)

69. Wang LF, Han ZB, Li M, Yang P, Xv B, Zhang JP, Han ZC.Recombinant hemangiopoietin promotes cell adhesion and binds heparin in its multimeric form.

Mol Med Rep. 2013 Mar;7(3):959-64. (SCI-IF:1.17)

70. Yang Y, Xue F, Shi H, Wang H, Zhang L, Ji L, Yang R. Acquired hemophilia A : Retrospective Analysis of 49 Cases From a Single Chinese Hemophilia Center.

Clin Appl Thromb Hemost.2013 May 14. (SCI-IF:1.016)

71. Ru YX, Bao ST, Dong SX, Zhao SX, Zhang FK, Zhu XF, Pang TX, Eyden B. Analysis of monocyte and histiocytic cell populations in bone marrow of patients with confirmed and suspected cases of reactive histocytosis.

Ultrastruct Pathol. 2013 Apr;37(2):93-101. (SCI-IF:0.978)

72. Li B, Xu Z, Gale RP, Qin T, Zhang Y, Xiao Z. Serum ferritin is an independent prognostic factor in Chinese with myelodysplastic syndromes classified as IPSS Intermediate-1.

Acta Haematol. 2013;129(4):243-50 (SCI-IF:0.894)